Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Nature - RMC-7977, a compound that exhibits potent inhibition of the active states of mutant and wild-type KRAS, NRAS and HRAS variants has a strong anti-tumour effect on RAS-addicted tumours and...
nature.com